List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1804 studies with search of: "GlaxoSmithKline" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
2 Completed Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Condition: Osteoarthritis, Knee
Intervention: Drug: GW406381
3 Completed Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine
Conditions: Haemophilus Influenzae Type b Disease;   Meningococcal Serogroup Diseases
Intervention: Biological: Haemophilus influenzae type b- and meningococcal (vaccine)
4 Completed
Has Results 		Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
5 Completed The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: rosiglitazone XR
6 Active, not recruiting A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
Conditions: Non-Insulin-Dependent Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention: Drug: Rosiglitazone maleate/metformin hydrochloride (AVANDAMET)
7 Completed SERETIDE 100/50 bd Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
Condition: Asthma
Intervention: Drug: SERETIDE FLIXOTIDE
8 Completed A Single Centre Study to Evaluate the Safety and Immunogenicity of the HPV Vaccine (GSK-580299) in Chinese Females
Condition: Human Papillomavirus (HPV) Infection
Intervention: Biological: Cervarix TM
9 Completed A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers
Condition: Healthy Subjects
Interventions: Drug: GSK961081;   Drug: Propanolol
10 Not yet recruiting Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Other: Retrospective analysis of already archived samples
11 Recruiting Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-Year-Old Children.
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Boostrix Polio™ 711866;   Biological: Priorix Tetra TM 208136;   Biological: Tetravac TM
12 Completed Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
Condition: Epilepsy
Intervention: Drug: lamotrigine
13 Completed Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-Acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects Followed by a 2 Year Extension.
Condition: Hypertriglyceridemia
Interventions: Drug: Simvastatin + Lovaza;   Drug: Simvastatin
14 Completed Effectiveness Of Single Doses Of Ibuprofen In Patients With Osteoarthritis Of The Knee
Condition: Osteoarthritis
Intervention: Drug: Ibuprofen
15 Completed A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
Condition: Schizophrenia
Intervention: Drug: SB- 773812
16 Terminated A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects
Condition: Healthy Volunteer
Intervention: Drug: Oseltamivir and Intravenous Zanamivir
17 Terminated GSK706769 A First Time in Human Study For Males and Females
Condition: Healthy Subjects
Intervention: Drug: GSK706769
18 Active, not recruiting Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™
Condition: Pneumococcal Disease
Interventions: Biological: GSK Biologicals' Zilbrix™ Hib;   Biological: Pneumococcal vaccine GSK1024850A;   Biological: GSK Biologicals' Polio Sabin™
19 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
20 Completed Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
Condition: Rotavirus Gastroenteritis
Interventions: Biological: Human Rotavirus Vaccine - two different formulations;   Biological: Prevnar;   Biological: IPOL;   Biological: Infanrix;   Biological: OmniHIB;   Biological: Pentacel;   Biological: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services